Nov 08, 2022 / 05:10PM GMT
Daniel Louis Leonard - Crédit Suisse AG - Research Division - Research Analyst
All right. With that, we'll kick things off. Thank you, everybody, for joining us. Next session is IQVIA. We're happy to have with us Ron Bruehlman, CFO. I'm Dan Leonard. I cover life science tools and services for Credit Suisse. And we'll kick things straight off. Ron, welcome.
Ronald E. Bruehlman - IQVIA Holdings Inc. - Executive VP & CFO
Thank you.
Questions and Answers:
Daniel Louis Leonard - Crédit Suisse AG - Research Division - Research AnalystSo you just closed up your Q3 -- reported Q3 earnings. Figured a good way to start off would be to remind us of the key highlights and takeaways from the Q3 report.
Ronald E. Bruehlman - IQVIA Holdings Inc. - Executive VP & CFO
Sure. Well, look, I think the #1 highlight, Dan, is that the market remains very strong for us. I know there's been concern, particularly about the emerging